Funder: European Commission
Due Dates: April 13, 2027: Full application submission deadline (single-stage topic)
Funding Amounts: €9,000,000–€10,000,000 per project | 4 grants expected | Project duration typically 3–5 years
Summary: Supports research to develop monoclonal antibodies for prevention and treatment of major emerging viral infections, advancing candidates toward clinical use and strengthening EU preparedness.
Key Information: Proposals must target one eligible virus; clinical study annex required; legal entities from China are not eligible.